Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer

Human Brain Mapping

Volumn 32, Issue 8, 2011, Pages 1206-1219

  de Ruiter, Michiel B ^a,b   Reneman, Liesbeth ^b   Boogerd, Willem ^a   Veltman, Dick J ^b,c   van Dam, Frits S A M ^a   Nederveen, Aart J ^b   Boven, Epie ^c   Schagen, Sanne B ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Breast cancer; Chemotherapy; Cognitive function; Functional magnetic resonance imaging; Late effects

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL; TAMOXIFEN; THIOTEPA;

ADULT; ARTICLE; ATTENTION; BOLD SIGNAL; BRAIN CORTEX; BREAST CANCER; CANCER ADJUVANT THERAPY; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG MEGADOSE; EPISODIC MEMORY; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; MEMORY CONSOLIDATION; MULTIPLE CYCLE TREATMENT; NEUROPSYCHOLOGICAL TEST; PARAHIPPOCAMPAL GYRUS; PLANNING; POSTERIOR PARIETAL CORTEX; PREFRONTAL CORTEX; PRIORITY JOURNAL; TASK PERFORMANCE;

ADULT; ANTINEOPLASTIC AGENTS; BRAIN; BRAIN MAPPING; BREAST NEOPLASMS; COGNITION; COGNITION DISORDERS; DATABASES, FACTUAL; EXECUTIVE FUNCTION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MENTAL RECALL; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS;

EID: 79960131410     PISSN: 10659471     EISSN: 10970193     Source Type: Journal    
DOI: 10.1002/hbm.21102     Document Type: Article

References (49)

1. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC (1993): The European organization for research and treatment of cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85: 365-376.
2. Ahles TA, Saykin AJ (2001): Cognitive effects of standard-dose chemotherapy in patients with cancer. Cancer Invest 19: 812-820.
3. Ahles TA, Saykin AJ (2007): Candidate mechanisms for chemotherapy-induced cognitive changes. Nat Rev Cancer 7: 192-201.
4. Alpherts W, Aldenkamp AP. 1994. FePsy: The Iron Psyche. Heemstede: Instituut voor Epilepsiebestrijding.
5. Cabeza R, Nyberg L (2000): Imaging cognition II: An empirical review of 275 PET and fMRI studies. J Cogn Neurosci 12: 1-47.
6. Chaytor N, Schmitter-Edgecombe M (2003): The ecological validity of neuropsychological tests: A review of the literature on everyday cognitive skills. Neuropsychol Rev 13: 181-197.
7. Correa DD, Ahles TA (2008): Neurocognitive changes in cancer survivors. Cancer J 14: 396-400.
8. Ferguson RJ, McDonald BC, Saykin AJ, Ahles TA (2007): Brain structure and function differences in monozygotic twins: Possible effects of breast cancer chemotherapy. J Clin Oncol 25: 3866-3870.
9. Fletcher PC, Henson RN (2001): Frontal lobes and human memory: Insights from functional neuroimaging. Brain 124: 849-881.
10. Genovese CR, Lazar NA, Nichols T (2002): Thresholding of statistical maps in functional neuroimaging using the false discovery rate. NeuroImage 15: 870-878.
11. Ghosh SS, Tourville JA, Guenther FH (2008): A neuroimaging study of premotor lateralization and cerebellar involvement in the production of phonemes and syllables. J Speech Lang Hear Res 51: 1183-1202.
12. Hammes J (1978): De Stroop Kleur-Woord Test. Handleiding, 2nd ed. Lisse: Swets & Zeitlinger.
13. Hesbacher PT, Rickels K, Morris RJ, Newman H, Rosenfeld H (1980): Psychiatric illness in family practice. J Clin Psychiatry 41: 6-10.
14. Indefrey P, Brown CM, Hellwig F, Amunts K, Herzog H, Seitz RJ, Hagoort P (2001): A neural correlate of syntactic encoding during speech production. Proc Natl Acad Sci USA 98: 5933-5936.
15. Jager G, Van Hell HH, De Win MM, Kahn RS, Van den Brink W, Van Ree JM, Ramsey NF (2007): Effects of frequent cannabis use on hippocampal activity during an associative memory task. Eur. Neuropsychopharmacol 17: 289-297.
16. Kreukels BP, Schagen SB, Ridderinkhof KR, Boogerd W, Hamburger HL, Muller MJ, van Dam FS (2006): Effects of high-dose and conventional-dose adjuvant chemotherapy on long-term cognitive sequelae in patients with breast cancer: An electrophysiologic study. Clin Breast Cancer 7: 67-78.
17. Kreukels BP, Hamburger HL, de Ruiter MB, van Dam FS, Ridderinkhof KR, Boogerd W, Schagen SB (2008): ERP amplitude and latency in breast cancer survivors treated with adjuvant chemotherapy. Clin Neurophysiol 119: 533-541.
18. Kumaran D, Maguire EA (2009): Novelty signals: A window into hippocampal information processing. Trends Cogn Sci 13: 47-54.
19. Lancaster JL, Woldorff MG, Parsons LM, Liotti M, Freitas CS, Rainey L, Kochunov PV, Nickerson D, Mikiten SA, Fox PT (2000): Automated Talairach atlas labels for functional brain mapping. Hum Brain Mapp 10: 120-131.
20. Levy R, Goldman-Rakic PS (2000): Segregation of working memory functions within the dorsolateral prefrontal cortex. Exp Brain Res 133: 23-32.
21. Lezak M (2004): Neuropsychological Assessment. New York: Oxford University Press.
22. Maldjian JA, Laurienti PJ, Kraft RA, Burdette JH (2003): An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. NeuroImage 19: 1233-1239.
23. Maldjian JA, Laurienti PJ, Burdette JH (2004): Precentral gyrus discrepancy in electronic versions of the Talairach atlas. NeuroImage 21: 50-455.
24. Meyers CA (2008): How chemotherapy damages the central nervous system. J Biol 7: 11.
25. Mulder JL, Dekker R, Dekker PH (1996): Verbale Leer en Geheugen Test. Lisse: Swets & Zeitlinger.
26. Reitan R (1958): Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills 8: 271-276.
27. Ries LAG, Melbert D, Krapcho M, Stinchcomb DG, Howlader N, Horner MJ, Mariotto A, Miller BA, Feuer EJ, Altekruse SF, Lewis DR, Clegg L, Eisner MP, Reichman M, Edwards BK (2008): SEER Cancer Statistics Review, 1975-2005. Bethesda: National Cancer Institute.
28. Rodenhuis S, Bontenbal M, Beex LV, Wagstaff J, Richel DJ, Nooij MA, Voest EE, Hupperets P, van Tinteren H, Peterse HL, TenVergert EM, de Vries EG (2003): High-dose chemotherapy with hematopoietic stem-cell rescue for high-risk breast cancer. N Engl J Med 349: 7-16.
29. Schagen SB, Vardy J (2007): Cognitive dysfunction in people with cancer. Lancet Oncol 8: 852-853.
30. Schagen SB, van Dam FS, Muller MJ, Boogerd W, Lindeboom J, Bruning PF (1999): Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer 85: 640-650.
31. Schagen SB, Hamburger HL, Muller MJ, Boogerd W, van Dam FS (2001): Neurophysiological evaluation of late effects of adjuvant high-dose chemotherapy on cognitive function. J Neurooncol 51: 159-165.
32. Schagen SB, Muller MJ, Boogerd W, Mellenbergh GJ, van Dam FS (2006): Change in cognitive function after chemotherapy: A prospective longitudinal study in breast cancer patients. J Natl Cancer Inst 98: 1742-1745.
33. Schilder CM, Eggens PC, Seynaeve C, Linn SC, Boogerd W, Gundy CM, Beex LV, van Dam FS, Schagen SB (2009): Neuropsychological functioning in postmenopausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy: Cross-sectional findings from the neuropsychological TEAM-side study. Acta Oncol 48: 76-85.
34. Schilder CM, Seynaeve C, Linn SC, Boogerd W, Gundy CM, Beex LV, van Dam FS, Schagen SB (2010): The impact of different definitions and reference groups on the prevalence of cognitive impairment: A study in postmenopausal breast cancer patients before the start of adjuvant systemic therapy. Psychooncology 19:415-422.
35. Schmand B, Lindeboom J, van Harskamp F (1992): De Nederlandse Leestest Voor Volwassenen. Lisse: Swets & Zeitlinger.
36. Shallice T (1982): Specific impairments of planning. Philos Trans R Soc Lond B Biol Sci 298: 199-209.
37. Silverman DH, Dy CJ, Castellon SA, Lai J, Pio BS, Abraham L, Waddell K, Petersen L, Phelps ME, Ganz PA (2007): Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy. Breast Cancer Res Treat 103: 303-311.
38. Tonkonogy J, Goodglass H (1981): Language function, foot of the third frontal gyrus, and rolandic operculum. Arch Neurol 38: 486-490.
39. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, Mazoyer B, Joliot M (2002): Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. NeuroImage 15: 273-289.
40. Ungerleider LG, Mishkin M (1982): Two cortical visual systems. In: Ingle DJ, Goodale MA, Mansfield RJW, editors. Analysis of Visual Behavior. Cambridge: MIT Press. pp 549-586.
41. van Dam, FS, Schagen SB, Muller MJ, Boogerd W, van der Wall E, Droogleever Fortuyn ME, Rodenhuis S (1998): Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: High-dose versus standard-dose chemotherapy. J Natl Cancer Inst 90: 210-218.
42. van den Heuvel OA, Groenewegen HJ, Barkhof F, Lazeron RH, van, Dyck R, Veltman DJ (2003): Frontostriatal system in planning complexity: A parametric functional magnetic resonance version of Tower of London task. NeuroImage 18: 367-374.
43. Vardy J, Wefel JS, Ahles T, Tannock IF, Schagen SB (2008): Cancer and cancer-therapy related cognitive dysfunction: An international perspective from the Venice cognitive workshop. Ann Oncol 19: 623-629.
44. Wager TD, Smith EE (2003): Neuroimaging studies of working memory: A meta-analysis. Cogn Affect Behav Neurosci 3: 255-274.
45. Wechsler D (1987): Wechsler Memory Scale: Revised. New York: Psychological Corporation.
46. Wechsler D (2000): WAIS-III. Nederlandstalige Bewerking. Technische Handleiding. Lisse: Swets & Zeitlinger.
47. Wefel JS, Witgert ME, Meyers CA (2008): Neuropsychological sequelae of non-central nervous system cancer and cancer therapy. Neuropsychol Rev 18: 121-131.
48. Weis J, Poppelreuter M, Bartsch HH (2009): Cognitive deficits as long-term side-effects of adjuvant therapy in breast cancer patients: "Subjective" complaints and "objective" neuropsychological test results. Psychooncology 18: 775-782.
49. Woods SP, Moore DJ, Weber E, Grant I (2009): Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychol Rev 19: 152-168.